Literature DB >> 11221818

Comparing mortality and time until death for medicare HMO and FFS beneficiaries.

M L Maciejewski1, B Dowd, K T Call, R Feldman.   

Abstract

OBJECTIVE: To compare adjusted mortality rates of TEFRA-risk HMO enrollees and disenrollees with rates of beneficiaries enrolled in the Medicare fee-for-service sector (FFS), and to compare the time until death for decedents in these three groups. DATA SOURCE: Data are from the 124 counties with the largest TEFRA-risk HMO enrollment using 1993-1994 Medicare Denominator files for beneficiaries enrolled in the FFS and TEFRA-risk HMO sectors. STUDY
DESIGN: A retrospective study that tracks the mortality rates and time until death of a random sample of 1,240,120 Medicare beneficiaries in the FFS sector and 1,526,502 enrollees in HMOs between April 1, 1993 and April 1, 1994. A total of 58,201 beneficiaries switched from an HMO to the FFS sector and were analyzed separately. PRINCIPAL
FINDINGS: HMO enrollees have lower relative odds of mortality than a comparable group of FFS beneficiaries. Conversely, HMO disenrollees have higher relative odds of mortality than comparable FFS beneficiaries. Among decedents in the three groups, HMO enrollees lived longer than FFS beneficiaries, who in turn lived longer than HMO disenrollees.
CONCLUSIONS: Medicare TEFRA-risk HMO enrollees appear to be, on average, healthier than beneficiaries enrolled in the FFS sector, who appear to be in turn healthier than HMO disenrollees. These health status differences persist, even after controlling for beneficiary demographics and county-level variables that might confound the relationship between mortality and the insurance sector.

Mesh:

Year:  2001        PMID: 11221818      PMCID: PMC1089189     

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  16 in total

1.  The current state of risk adjustment technology for capitation.

Authors:  M J Ingber
Journal:  J Ambul Care Manage       Date:  1998-10

2.  Medicare HMOs: who joins and who leaves?

Authors:  B A Virnig; R O Morgan; C A DeVito; N A Persily
Journal:  Am J Manag Care       Date:  1998-04       Impact factor: 2.229

3.  Risk Adjustment for the Medicare program: lessons learned from research and demonstrations.

Authors:  L M Greenwald; A Esposito; M J Ingber; J M Levy
Journal:  Inquiry       Date:  1998       Impact factor: 1.730

4.  The Medicare-HMO revolving door--the healthy go in and the sick go out.

Authors:  R O Morgan; B A Virnig; C A DeVito; N A Persily
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

5.  Managed care plan performance since 1980. A literature analysis.

Authors:  R H Miller; H S Luft
Journal:  JAMA       Date:  1994-05-18       Impact factor: 56.272

6.  Disenrollment of Medicare cancer patients from health maintenance organizations.

Authors:  G F Riley; E J Feuer; J D Lubitz
Journal:  Med Care       Date:  1996-08       Impact factor: 2.983

7.  Access and outcomes of elderly patients enrolled in managed care.

Authors:  D G Clement; S M Retchin; R S Brown; M H Stegall
Journal:  JAMA       Date:  1994-05-18       Impact factor: 56.272

8.  An analysis of selectivity bias in the Medicare AAPCC (adjusted average per capita cost).

Authors:  B Dowd; R Feldman; I Moscovice; C Wisner; P Bland; M Finch
Journal:  Health Care Financ Rev       Date:  1996

9.  Pre-enrollment reimbursement patterns of Medicare beneficiaries enrolled in "at-risk" HMOs.

Authors:  P W Eggers; R Prihoda
Journal:  Health Care Financ Rev       Date:  1982-09

10.  Risk differential between Medicare beneficiaries enrolled and not enrolled in an HMO.

Authors:  P Eggers
Journal:  Health Care Financ Rev       Date:  1980
View more
  15 in total

1.  Understanding biased selection in Medicare HMOs.

Authors:  Michelle M Mello; Sally C Stearns; Edward C Norton; Thomas C Ricketts
Journal:  Health Serv Res       Date:  2003-06       Impact factor: 3.402

2.  Multiple prior years of health expenditures and Medicare health plan choice.

Authors:  Matthew L Maciejewski; Bryan Dowd; Heidi O'Connor
Journal:  Int J Health Care Finance Econ       Date:  2004-09

3.  Determining population based mortality risk in the Department of Veterans Affairs.

Authors:  Theodore Stefos; Laura Lehner; Marta Render; Eileen Moran; Peter Almenoff
Journal:  Health Care Manag Sci       Date:  2011-12-14

4.  Impact of continued biased disenrollment from the Medicare Advantage Program to fee-for-service.

Authors:  Gerald F Riley
Journal:  Medicare Medicaid Res Rev       Date:  2012-01-30

5.  Do primary care physicians lose contact with their colorectal cancer patients?

Authors:  Sharon Dobie; Barry G Saver; Ching-Yun Wang; Pamela K Green; Laura-Mae Baldwin
Journal:  J Am Board Fam Med       Date:  2011 Nov-Dec       Impact factor: 2.657

6.  Certificate of Need (CON) for cardiac care: controversy over the contributions of CON.

Authors:  Vivian Ho; Meei-Hsiang Ku-Goto; James G Jollis
Journal:  Health Serv Res       Date:  2008-12-15       Impact factor: 3.402

7.  Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosis.

Authors:  Elena B Elkin; Nicole Ishill; Gerald F Riley; Peter B Bach; Mithat Gonen; Colin B Begg; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2008-07-08       Impact factor: 13.506

8.  The costs of decedents in the Medicare program: implications for payments to Medicare + Choice plans.

Authors:  Melinda Beeuwkes Buntin; Alan M Garber; Mark McClellan; Joseph P Newhouse
Journal:  Health Serv Res       Date:  2004-02       Impact factor: 3.402

9.  Association between visit-to-visit HbA1c variability and the risk of cardiovascular disease in patients with type 2 diabetes.

Authors:  Yun Shen; Jian Zhou; Lizheng Shi; Elizabeth Nauman; Peter T Katzmarzyk; Eboni G Price-Haywood; Ronald Horswell; Alessandra N Bazzano; Somesh Nigam; Gang Hu
Journal:  Diabetes Obes Metab       Date:  2020-10-07       Impact factor: 6.577

10.  Trends in the health status of medicare risk contract enrollees.

Authors:  Gerald Riley; Carlos Zarabozo
Journal:  Health Care Financ Rev       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.